Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 35 | 2024 | 1272 | 5.300 |
Why?
|
Endovascular Procedures | 37 | 2024 | 2181 | 4.390 |
Why?
|
Ischemia | 35 | 2024 | 1876 | 3.970 |
Why?
|
Limb Salvage | 26 | 2024 | 481 | 2.450 |
Why?
|
Vascular Surgical Procedures | 21 | 2024 | 1490 | 2.410 |
Why?
|
Lower Extremity | 14 | 2024 | 1201 | 2.380 |
Why?
|
Popliteal Artery | 5 | 2024 | 310 | 1.800 |
Why?
|
Blood Vessel Prosthesis Implantation | 14 | 2024 | 1427 | 1.540 |
Why?
|
Peripheral Vascular Diseases | 4 | 2023 | 488 | 1.400 |
Why?
|
Stents | 12 | 2020 | 3179 | 1.320 |
Why?
|
Saphenous Vein | 9 | 2024 | 518 | 1.180 |
Why?
|
Vascular Patency | 11 | 2024 | 910 | 1.140 |
Why?
|
Vascular Grafting | 11 | 2024 | 162 | 0.950 |
Why?
|
Angioplasty, Balloon | 3 | 2016 | 588 | 0.880 |
Why?
|
Decompression, Surgical | 2 | 2024 | 608 | 0.860 |
Why?
|
Blood Vessel Prosthesis | 5 | 2021 | 954 | 0.740 |
Why?
|
Intermittent Claudication | 2 | 2016 | 304 | 0.700 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2022 | 1230 | 0.690 |
Why?
|
Extremities | 2 | 2016 | 867 | 0.680 |
Why?
|
Treatment Outcome | 59 | 2024 | 64645 | 0.680 |
Why?
|
Arterial Occlusive Diseases | 5 | 2024 | 748 | 0.630 |
Why?
|
Femoral Artery | 4 | 2018 | 827 | 0.610 |
Why?
|
Treatment Failure | 1 | 2024 | 2642 | 0.600 |
Why?
|
Renal Artery | 5 | 2021 | 351 | 0.580 |
Why?
|
Aneurysm | 2 | 2010 | 337 | 0.560 |
Why?
|
Aneurysm, Infected | 3 | 2014 | 81 | 0.530 |
Why?
|
Time Factors | 35 | 2024 | 39974 | 0.510 |
Why?
|
Recurrence | 5 | 2024 | 8470 | 0.510 |
Why?
|
Research Design | 4 | 2024 | 6178 | 0.500 |
Why?
|
Reoperation | 12 | 2024 | 4302 | 0.490 |
Why?
|
Renal Artery Obstruction | 3 | 2021 | 219 | 0.460 |
Why?
|
Veins | 4 | 2023 | 768 | 0.450 |
Why?
|
Hemodynamics | 1 | 2024 | 4167 | 0.450 |
Why?
|
Risk Factors | 36 | 2024 | 74152 | 0.420 |
Why?
|
Transposition of Great Vessels | 1 | 2017 | 594 | 0.420 |
Why?
|
Quality of Life | 8 | 2024 | 13355 | 0.390 |
Why?
|
Polyethylene Terephthalates | 1 | 2012 | 115 | 0.390 |
Why?
|
Iliac Artery | 3 | 2019 | 343 | 0.340 |
Why?
|
Renal Veins | 1 | 2009 | 102 | 0.330 |
Why?
|
Patient Care Team | 3 | 2015 | 2523 | 0.330 |
Why?
|
Angioplasty | 1 | 2012 | 354 | 0.320 |
Why?
|
Critical Illness | 12 | 2024 | 2722 | 0.320 |
Why?
|
Brachytherapy | 1 | 2016 | 1223 | 0.320 |
Why?
|
Graft Occlusion, Vascular | 3 | 2024 | 537 | 0.310 |
Why?
|
Retrospective Studies | 39 | 2024 | 80575 | 0.310 |
Why?
|
Aneurysm, False | 3 | 2020 | 254 | 0.300 |
Why?
|
Debridement | 2 | 2010 | 493 | 0.300 |
Why?
|
Humans | 99 | 2024 | 761326 | 0.290 |
Why?
|
Pericardium | 1 | 2012 | 675 | 0.280 |
Why?
|
Device Removal | 3 | 2021 | 630 | 0.280 |
Why?
|
Kaplan-Meier Estimate | 9 | 2024 | 6473 | 0.270 |
Why?
|
Endarterectomy, Carotid | 1 | 2012 | 555 | 0.270 |
Why?
|
Ultrasonography, Doppler, Duplex | 3 | 2024 | 198 | 0.270 |
Why?
|
Proportional Hazards Models | 10 | 2024 | 12450 | 0.250 |
Why?
|
Chronic Disease | 7 | 2024 | 9319 | 0.250 |
Why?
|
Arteriovenous Shunt, Surgical | 2 | 2022 | 292 | 0.240 |
Why?
|
Carotid Stenosis | 1 | 2012 | 860 | 0.230 |
Why?
|
Leg | 3 | 2016 | 1089 | 0.230 |
Why?
|
Viscera | 1 | 2004 | 138 | 0.220 |
Why?
|
Ankle Brachial Index | 1 | 2024 | 163 | 0.220 |
Why?
|
Postoperative Complications | 14 | 2024 | 15647 | 0.220 |
Why?
|
Constriction, Pathologic | 3 | 2024 | 1097 | 0.220 |
Why?
|
Thymus Gland | 3 | 2004 | 1241 | 0.220 |
Why?
|
Chi-Square Distribution | 6 | 2016 | 3419 | 0.210 |
Why?
|
Heart Transplantation | 8 | 2005 | 3234 | 0.210 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2024 | 97 | 0.210 |
Why?
|
Recovery of Function | 3 | 2024 | 2977 | 0.210 |
Why?
|
Aged | 48 | 2024 | 169179 | 0.200 |
Why?
|
Research Subjects | 2 | 2021 | 249 | 0.200 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2010 | 696 | 0.200 |
Why?
|
Arteries | 1 | 2007 | 1125 | 0.200 |
Why?
|
Male | 59 | 2024 | 360621 | 0.190 |
Why?
|
Patient Selection | 7 | 2024 | 4244 | 0.190 |
Why?
|
Middle Aged | 45 | 2024 | 220774 | 0.190 |
Why?
|
Female | 58 | 2024 | 392485 | 0.170 |
Why?
|
Vascular Fistula | 1 | 2020 | 50 | 0.170 |
Why?
|
Mesenteric Artery, Superior | 2 | 2014 | 95 | 0.170 |
Why?
|
Gift Giving | 1 | 2020 | 76 | 0.170 |
Why?
|
Multivariate Analysis | 8 | 2024 | 12059 | 0.170 |
Why?
|
Financial Support | 1 | 2020 | 117 | 0.170 |
Why?
|
Alloys | 1 | 2019 | 110 | 0.170 |
Why?
|
Intestinal Fistula | 1 | 2020 | 142 | 0.160 |
Why?
|
Risk Assessment | 14 | 2024 | 23981 | 0.160 |
Why?
|
Subclavian Artery | 1 | 2019 | 134 | 0.160 |
Why?
|
Aged, 80 and over | 22 | 2024 | 58946 | 0.160 |
Why?
|
Cardiovascular Abnormalities | 1 | 2019 | 143 | 0.160 |
Why?
|
Credentialing | 1 | 2019 | 116 | 0.160 |
Why?
|
Boston | 4 | 2016 | 9333 | 0.160 |
Why?
|
Health Care Sector | 1 | 2020 | 194 | 0.150 |
Why?
|
Prospective Studies | 12 | 2024 | 54405 | 0.150 |
Why?
|
Research Personnel | 2 | 2019 | 588 | 0.140 |
Why?
|
Databases, Factual | 6 | 2024 | 7954 | 0.140 |
Why?
|
Myxoma | 1 | 2017 | 114 | 0.140 |
Why?
|
Vascular Diseases | 3 | 2024 | 1161 | 0.140 |
Why?
|
Embolectomy | 1 | 2017 | 129 | 0.140 |
Why?
|
Aorta, Thoracic | 3 | 2011 | 1097 | 0.140 |
Why?
|
Magnetic Resonance Angiography | 4 | 2021 | 1432 | 0.140 |
Why?
|
Sample Size | 1 | 2019 | 839 | 0.130 |
Why?
|
Prosthesis-Related Infections | 1 | 2021 | 488 | 0.130 |
Why?
|
Intraoperative Care | 1 | 2019 | 766 | 0.130 |
Why?
|
North America | 2 | 2019 | 1275 | 0.130 |
Why?
|
Aortography | 2 | 2018 | 420 | 0.120 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2015 | 26 | 0.120 |
Why?
|
Retreatment | 1 | 2016 | 598 | 0.120 |
Why?
|
Frail Elderly | 1 | 2020 | 763 | 0.120 |
Why?
|
Comprehension | 1 | 2020 | 621 | 0.120 |
Why?
|
Hematoma | 2 | 2012 | 768 | 0.120 |
Why?
|
Embolism | 1 | 2017 | 400 | 0.120 |
Why?
|
Specialization | 1 | 2019 | 779 | 0.120 |
Why?
|
Heart Neoplasms | 1 | 2017 | 362 | 0.110 |
Why?
|
Thrombosis | 2 | 2022 | 2942 | 0.110 |
Why?
|
Informed Consent | 1 | 2020 | 1008 | 0.110 |
Why?
|
Deglutition Disorders | 1 | 2019 | 627 | 0.110 |
Why?
|
Registries | 4 | 2021 | 8223 | 0.110 |
Why?
|
Aorta | 1 | 2021 | 2042 | 0.110 |
Why?
|
Angiography | 2 | 2016 | 1599 | 0.110 |
Why?
|
Interdisciplinary Communication | 2 | 2019 | 931 | 0.110 |
Why?
|
Vocal Cord Paralysis | 2 | 2009 | 272 | 0.110 |
Why?
|
Emergencies | 1 | 2019 | 1217 | 0.110 |
Why?
|
Anastomosis, Surgical | 1 | 2016 | 983 | 0.100 |
Why?
|
Cost-Benefit Analysis | 2 | 2016 | 5492 | 0.100 |
Why?
|
Aortic Diseases | 1 | 2018 | 737 | 0.100 |
Why?
|
Reading | 1 | 1996 | 529 | 0.100 |
Why?
|
Endoleak | 1 | 2012 | 111 | 0.100 |
Why?
|
Lipids | 1 | 2023 | 3341 | 0.100 |
Why?
|
Cyclosporine | 4 | 2004 | 778 | 0.100 |
Why?
|
Kidney Transplantation | 4 | 2021 | 4236 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10203 | 0.090 |
Why?
|
Tomography, Spiral Computed | 1 | 2012 | 273 | 0.090 |
Why?
|
Radiography | 4 | 2014 | 6966 | 0.090 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 709 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2017 | 946 | 0.090 |
Why?
|
Esophageal Cyst | 1 | 2010 | 13 | 0.090 |
Why?
|
Syndrome | 2 | 2024 | 3268 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1866 | 0.090 |
Why?
|
Survival Rate | 6 | 2020 | 12710 | 0.090 |
Why?
|
Regional Blood Flow | 1 | 2014 | 1495 | 0.090 |
Why?
|
Paranasal Sinus Neoplasms | 4 | 1994 | 242 | 0.090 |
Why?
|
New England | 1 | 2013 | 1053 | 0.080 |
Why?
|
Streptococcal Infections | 1 | 2014 | 616 | 0.080 |
Why?
|
Aortitis | 1 | 2010 | 74 | 0.080 |
Why?
|
Substance Abuse, Intravenous | 1 | 2014 | 530 | 0.080 |
Why?
|
Flank Pain | 1 | 2009 | 43 | 0.080 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 166 | 0.080 |
Why?
|
Aneurysm, Ruptured | 1 | 2014 | 463 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2015 | 1440 | 0.080 |
Why?
|
Pain | 1 | 2024 | 5077 | 0.080 |
Why?
|
Tunica Intima | 1 | 2011 | 459 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 4014 | 0.080 |
Why?
|
Renal Dialysis | 2 | 2022 | 1801 | 0.080 |
Why?
|
Phlebography | 1 | 2009 | 326 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2016 | 1958 | 0.080 |
Why?
|
Hematuria | 1 | 2009 | 233 | 0.080 |
Why?
|
Postoperative Hemorrhage | 1 | 2012 | 415 | 0.080 |
Why?
|
Cardiology | 1 | 2019 | 1667 | 0.080 |
Why?
|
Propensity Score | 2 | 2013 | 1908 | 0.070 |
Why?
|
Laryngeal Neoplasms | 3 | 2004 | 514 | 0.070 |
Why?
|
Varicose Veins | 1 | 2009 | 155 | 0.070 |
Why?
|
Hypoparathyroidism | 1 | 2009 | 136 | 0.070 |
Why?
|
Upper Extremity | 1 | 2012 | 657 | 0.070 |
Why?
|
Neck Dissection | 1 | 2009 | 201 | 0.070 |
Why?
|
Ethmoid Sinus | 3 | 1994 | 57 | 0.070 |
Why?
|
Visual Perception | 1 | 1996 | 1385 | 0.070 |
Why?
|
Prostheses and Implants | 2 | 2005 | 1272 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3687 | 0.070 |
Why?
|
Tibial Arteries | 1 | 2007 | 60 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7389 | 0.070 |
Why?
|
Adult | 22 | 2024 | 221122 | 0.070 |
Why?
|
Graft Survival | 5 | 2005 | 3818 | 0.070 |
Why?
|
Pharyngeal Neoplasms | 4 | 1988 | 113 | 0.070 |
Why?
|
Swine | 8 | 2005 | 5915 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3597 | 0.070 |
Why?
|
Prosthesis Design | 3 | 2012 | 2115 | 0.070 |
Why?
|
Cattle | 1 | 2012 | 3849 | 0.070 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15835 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 6 | 2014 | 20555 | 0.060 |
Why?
|
Inguinal Canal | 1 | 2005 | 71 | 0.060 |
Why?
|
Cyanoacrylates | 1 | 2005 | 46 | 0.060 |
Why?
|
Cerebrovascular Circulation | 1 | 1996 | 2727 | 0.060 |
Why?
|
Immunosuppressive Agents | 5 | 2005 | 4173 | 0.060 |
Why?
|
United States | 10 | 2024 | 72317 | 0.060 |
Why?
|
Iliac Vein | 1 | 2004 | 70 | 0.060 |
Why?
|
Swine, Miniature | 6 | 2005 | 961 | 0.060 |
Why?
|
Comorbidity | 3 | 2016 | 10498 | 0.060 |
Why?
|
Tissue Adhesives | 1 | 2005 | 173 | 0.060 |
Why?
|
Thyroid Cartilage | 1 | 2003 | 43 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3510 | 0.060 |
Why?
|
Transplantation Chimera | 3 | 2001 | 594 | 0.060 |
Why?
|
Mycophenolic Acid | 1 | 2005 | 348 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 699 | 0.050 |
Why?
|
Intention to Treat Analysis | 1 | 2024 | 414 | 0.050 |
Why?
|
Glottis | 1 | 2004 | 214 | 0.050 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1525 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6815 | 0.050 |
Why?
|
Cisplatin | 6 | 2002 | 1647 | 0.050 |
Why?
|
Lymphoma, Follicular | 1 | 2006 | 457 | 0.050 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2004 | 1445 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2004 | 1355 | 0.050 |
Why?
|
Prevalence | 2 | 2019 | 15719 | 0.050 |
Why?
|
Health Care Costs | 1 | 2015 | 3243 | 0.050 |
Why?
|
Anesthesia, Local | 1 | 2003 | 277 | 0.050 |
Why?
|
Transplantation, Homologous | 4 | 2004 | 4810 | 0.050 |
Why?
|
Aortic Rupture | 1 | 2004 | 319 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2004 | 4022 | 0.050 |
Why?
|
Young Adult | 3 | 2024 | 59196 | 0.050 |
Why?
|
Vena Cava, Inferior | 1 | 2024 | 459 | 0.040 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2000 | 57 | 0.040 |
Why?
|
Adolescent | 5 | 2024 | 88305 | 0.040 |
Why?
|
Length of Stay | 3 | 2021 | 6422 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2004 | 11735 | 0.040 |
Why?
|
Ferrosoferric Oxide | 1 | 2021 | 348 | 0.040 |
Why?
|
Sarcoma | 1 | 2011 | 1793 | 0.040 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 940 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4936 | 0.040 |
Why?
|
Isoantigens | 1 | 2001 | 552 | 0.040 |
Why?
|
Homozygote | 1 | 2004 | 1796 | 0.040 |
Why?
|
New Zealand | 1 | 2019 | 357 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2004 | 1530 | 0.040 |
Why?
|
Combined Modality Therapy | 11 | 2015 | 8526 | 0.040 |
Why?
|
Heart Function Tests | 1 | 2019 | 318 | 0.040 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39108 | 0.040 |
Why?
|
Graft Rejection | 5 | 2005 | 4446 | 0.040 |
Why?
|
Carotid Artery Diseases | 1 | 2005 | 877 | 0.040 |
Why?
|
Deglutition | 1 | 2019 | 208 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5841 | 0.040 |
Why?
|
Transplantation Immunology | 1 | 2000 | 532 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 2022 | 1370 | 0.040 |
Why?
|
Algorithms | 2 | 2016 | 14025 | 0.040 |
Why?
|
Haplotypes | 1 | 2004 | 2774 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2011 | 6478 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2019 | 267 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2004 | 1783 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2017 | 335 | 0.030 |
Why?
|
Skin Transplantation | 1 | 2001 | 1083 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2120 | 0.030 |
Why?
|
Thyroid Neoplasms | 1 | 2009 | 2332 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2004 | 2385 | 0.030 |
Why?
|
Preoperative Care | 1 | 2024 | 2242 | 0.030 |
Why?
|
Conflict of Interest | 1 | 2020 | 554 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2002 | 1110 | 0.030 |
Why?
|
Blood Pressure | 1 | 2010 | 8485 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4321 | 0.030 |
Why?
|
Coronary Disease | 2 | 2000 | 5919 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2021 | 5291 | 0.030 |
Why?
|
Thymectomy | 3 | 2000 | 194 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2010 | 7439 | 0.030 |
Why?
|
Specialties, Surgical | 1 | 2019 | 389 | 0.030 |
Why?
|
Disclosure | 1 | 2020 | 748 | 0.030 |
Why?
|
Papilloma, Inverted | 1 | 1994 | 19 | 0.030 |
Why?
|
Odds Ratio | 2 | 2016 | 9639 | 0.030 |
Why?
|
Immune Tolerance | 2 | 2000 | 2300 | 0.030 |
Why?
|
Medicare | 2 | 2024 | 6758 | 0.030 |
Why?
|
Organ Transplantation | 1 | 2004 | 1157 | 0.030 |
Why?
|
Geniculate Bodies | 1 | 1994 | 160 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2004 | 5866 | 0.030 |
Why?
|
Survival Analysis | 2 | 2004 | 10075 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1996 | 1122 | 0.030 |
Why?
|
Dyslexia | 1 | 1994 | 208 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2018 | 1204 | 0.030 |
Why?
|
International Cooperation | 1 | 2019 | 1428 | 0.030 |
Why?
|
Pancreatic Elastase | 1 | 2012 | 128 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3420 | 0.030 |
Why?
|
Laryngeal Cartilages | 1 | 1992 | 23 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2009 | 9275 | 0.030 |
Why?
|
Carcinoma | 3 | 2009 | 2328 | 0.030 |
Why?
|
Animals | 9 | 2012 | 168388 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1504 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 2017 | 1281 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2019 | 1535 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2004 | 4550 | 0.020 |
Why?
|
Actuarial Analysis | 4 | 1994 | 374 | 0.020 |
Why?
|
Nose Neoplasms | 1 | 1994 | 249 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2005 | 2891 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2000 | 2049 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2002 | 2823 | 0.020 |
Why?
|
Heart | 1 | 2004 | 4405 | 0.020 |
Why?
|
Hearing | 1 | 1994 | 501 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2319 | 0.020 |
Why?
|
Carcinoid Tumor | 1 | 1992 | 224 | 0.020 |
Why?
|
Endocarditis, Bacterial | 1 | 2014 | 444 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2011 | 2009 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11070 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15262 | 0.020 |
Why?
|
Bleomycin | 2 | 1988 | 494 | 0.020 |
Why?
|
Probability | 2 | 2005 | 2478 | 0.020 |
Why?
|
Motivation | 1 | 2019 | 2006 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26108 | 0.020 |
Why?
|
Stroke | 1 | 2012 | 9749 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3122 | 0.020 |
Why?
|
Functional Laterality | 1 | 1996 | 2256 | 0.020 |
Why?
|
Lactobacillus | 1 | 2010 | 212 | 0.020 |
Why?
|
Radiopharmaceuticals | 2 | 2011 | 2650 | 0.020 |
Why?
|
Databases as Topic | 1 | 2011 | 473 | 0.020 |
Why?
|
Neoplasm Staging | 5 | 2011 | 11098 | 0.020 |
Why?
|
Ear Neoplasms | 1 | 1989 | 118 | 0.020 |
Why?
|
Visual Cortex | 1 | 1996 | 1107 | 0.020 |
Why?
|
Pharyngectomy | 1 | 1988 | 44 | 0.020 |
Why?
|
Ear Canal | 1 | 1989 | 147 | 0.020 |
Why?
|
Fluorouracil | 5 | 1994 | 1637 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2014 | 1071 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2010 | 351 | 0.020 |
Why?
|
Skin | 1 | 2001 | 4482 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3905 | 0.020 |
Why?
|
Contrast Media | 2 | 2012 | 5310 | 0.020 |
Why?
|
Ear, Middle | 1 | 1989 | 339 | 0.020 |
Why?
|
Endosonography | 1 | 2010 | 610 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3801 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3889 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3204 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2010 | 1118 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4850 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 12972 | 0.010 |
Why?
|
Intracranial Aneurysm | 1 | 2014 | 1285 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6231 | 0.010 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2014 | 1555 | 0.010 |
Why?
|
Axilla | 1 | 2006 | 624 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2002 | 5303 | 0.010 |
Why?
|
Thyroidectomy | 1 | 2009 | 907 | 0.010 |
Why?
|
Carotid Artery, Internal | 1 | 2005 | 445 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 21336 | 0.010 |
Why?
|
Esophagus | 1 | 1988 | 1030 | 0.010 |
Why?
|
Voice Quality | 1 | 2003 | 226 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2006 | 876 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2010 | 1671 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8635 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13251 | 0.010 |
Why?
|
Accidents, Traffic | 1 | 2006 | 816 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2005 | 2115 | 0.010 |
Why?
|
Leukocyte Transfusion | 1 | 2000 | 56 | 0.010 |
Why?
|
Morbidity | 1 | 2005 | 1750 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1996 | 5776 | 0.010 |
Why?
|
Mouth Neoplasms | 1 | 1985 | 596 | 0.010 |
Why?
|
Cicatrix | 1 | 2005 | 798 | 0.010 |
Why?
|
Catheterization | 1 | 2005 | 1432 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18401 | 0.010 |
Why?
|
Massachusetts | 1 | 2012 | 8837 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2012 | 12329 | 0.010 |
Why?
|
Lymph Node Excision | 3 | 1992 | 1273 | 0.010 |
Why?
|
Laryngectomy | 2 | 1992 | 243 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2002 | 13333 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 1988 | 1647 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 1999 | 719 | 0.010 |
Why?
|
Major Histocompatibility Complex | 1 | 2000 | 927 | 0.010 |
Why?
|
Transplantation Tolerance | 1 | 2001 | 605 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2000 | 1351 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 1994 | 6332 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2002 | 2898 | 0.010 |
Why?
|
Neurons | 1 | 1994 | 9458 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2006 | 3469 | 0.010 |
Why?
|
Wound Healing | 1 | 2005 | 2802 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 2 | 1994 | 3512 | 0.010 |
Why?
|
Ethmoid Bone | 1 | 1994 | 35 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2005 | 3460 | 0.010 |
Why?
|
Cohort Studies | 2 | 2005 | 41440 | 0.010 |
Why?
|
Tissue Donors | 1 | 2001 | 2331 | 0.010 |
Why?
|
Remission Induction | 1 | 1994 | 2395 | 0.000 |
Why?
|
Hematopoietic Stem Cells | 1 | 2000 | 3396 | 0.000 |
Why?
|
Reference Values | 1 | 1994 | 4921 | 0.000 |
Why?
|
Myocardium | 1 | 2000 | 4723 | 0.000 |
Why?
|
Neck | 1 | 1992 | 735 | 0.000 |
Why?
|
Child | 1 | 2015 | 80156 | 0.000 |
Why?
|
Vincristine | 1 | 1988 | 1036 | 0.000 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 1985 | 51 | 0.000 |
Why?
|
Endoscopy | 1 | 1994 | 1851 | 0.000 |
Why?
|
Models, Biological | 1 | 1999 | 9468 | 0.000 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2001 | 5670 | 0.000 |
Why?
|
Neoplasm Invasiveness | 1 | 1991 | 3588 | 0.000 |
Why?
|
Cyclophosphamide | 1 | 1988 | 2218 | 0.000 |
Why?
|
Methotrexate | 1 | 1988 | 1720 | 0.000 |
Why?
|
Prognosis | 2 | 1994 | 29588 | 0.000 |
Why?
|
Oropharyngeal Neoplasms | 1 | 1985 | 491 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1986 | 2914 | 0.000 |
Why?
|